© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 15, 1159-1165,
August 1, 2001
© 2001 Oxford University Press
REPORT |
RBP1L1, a Retinoblastoma-Binding Protein-Related Gene Encoding an Antigenic Epitope Abundantly Expressed in Human Carcinomas and Normal Testis
Affiliations of authors: J. Cao, Department of Biotechnology Sciences, John Wayne Cancer Institute, Santa Monica, CA, and Department of Microbiology and Molecular Genetics, College of Medicine, University of California, Irvine; T. Gao, R. Irie, Department of Biotechnology Sciences, John Wayne Cancer Institute; E. J. Stanbridge, Department of Microbiology and Molecular Genetics, College of Medicine, University of California, Irvine.
Correspondence to: Jia-ning Cao, M.D., Department of Microbiology and Molecular Genetics, College of Medicine, University of California, Irvine, CA 92697–4025 (e-mail: jcao{at}uci.edu).
Background: Antibodies isolated from cancer patients have been used to identify genes encoding tumor-associated antigen epitopes relevant to immune responses in cancer patients. In this report, we used an immunoglobulin G (IgG) purified from serum of a patient with breast cancer to identify its corresponding epitope, gene, and protein—retinoblastoma-binding protein-1-like protein-1 (RBP1L1)—and determined whether it is a potential molecular marker for various cancers. Methods: IgG purified from the serum of a patient with breast cancer was used to screen an MCF-7 breast cancer cell complementary DNA (cDNA) expression library for immunoreactive clones. The cDNAs identified were cloned and sequenced. Immunoreactivity of specific amino acids in the epitope was determined by western blot analysis and enzyme-linked immunosorbent assay. The cellular location of the antigen was determined by immunoperoxidase staining with purified RBP1L1-specific IgG. Gene expression in various human carcinomas and normal tissues was examined by northern blot analysis and the reverse transcription–polymerase chain reaction. Results: Our purified IgG recognized just one epitope on RBP1L1. The complete 5802-base-pair RBP1L1 cDNA encodes a 1226-amino acid protein containing the antigenic epitope IKPSLGSKK. The derived protein sequence of RBP1L1 shares 74% and 37% amino acid identity, respectively, with a partial sequence of the retinoblastoma-binding protein and the complete sequence of retinoblastoma-binding protein-1. The RBP1L1 epitope was localized to the cytoplasm of MCF-7 cells but was not detected in peripheral blood mononuclear cells. High expression of RBP1L1 messenger RNA was found in human breast, lung, colon, pancreatic, and ovarian cancers and in normal testis, but expression was limited in other normal tissues. Conclusions: RBP1L1 appears to be a molecular marker associated with a broad range of human malignancies.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M.-Y. Wu, K. W. Eldin, and A. L. Beaudet Identification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor Genes J Natl Cancer Inst, September 3, 2008; 100(17): 1247 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-Y. Wu, T.-F. Tsai, and A. L. Beaudet Deficiency of Rbbp1/Arid4a and Rbbp1l1/Arid4b alters epigenetic modifications and suppresses an imprinting defect in the PWS/AS domain. Genes & Dev., October 15, 2006; 20(20): 2859 - 2870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kobayashi, T. Era, A. Takebe, L. M. Jakt, and S.-I. Nishikawa ARID3B Induces Malignant Transformation of Mouse Embryonic Fibroblasts and Is Strongly Associated with Malignant Neuroblastoma. Cancer Res., September 1, 2006; 66(17): 8331 - 8336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Binda, J.-S. Roy, and P. E. Branton RBP1 Family Proteins Exhibit SUMOylation-Dependent Transcriptional Repression and Induce Cell Growth Inhibition Reminiscent of Senescence. Mol. Cell. Biol., March 1, 2006; 26(5): 1917 - 1931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Abdul-Rasool, S H Kidson, E Panieri, D Dent, K Pillay, and G S Hanekom An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes. J. Clin. Pathol., March 1, 2006; 59(3): 289 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Patsialou, D. Wilsker, and E. Moran DNA-binding properties of ARID family proteins Nucleic Acids Res., January 7, 2005; 33(1): 66 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Cui, G. Jin, T. Gao, T. Sun, F. Tian, G. G. Estrada, H. Gao, and A. Sarai Characterization of BRCAA1 and Its Novel Antigen Epitope Identification Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1136 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wilsker, A. Patsialou, P. B. Dallas, and E. Moran ARID Proteins: A Diverse Family of DNA Binding Proteins Implicated in the Control of Cell Growth, Differentiation, and Development Cell Growth Differ., March 1, 2002; 13(3): 95 - 106. [Abstract] [Full Text] [PDF]
|
|